The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients
Authors
Keywords
Pancreatic cancer, Elderly, Nab paclitaxel, Gemcitabine
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 84, Issue 3, Pages 647-654
Publisher
Springer Science and Business Media LLC
Online
2019-06-23
DOI
10.1007/s00280-019-03895-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)
- (2018) Johannes Betge et al. BMC CANCER
- Combination therapy versus gemcitabine monotherapy in the treatment of elderly pancreatic cancer: a meta-analysis of randomized controlled trials
- (2018) Jiamin Jin et al. Drug Design Development and Therapy
- Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis
- (2018) Felice N. van Erning et al. ACTA ONCOLOGICA
- Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis
- (2017) Qingcai Meng et al. OncoTargets and Therapy
- NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice
- (2016) Ferdinando De Vita et al. BMC CANCER
- Management of pancreatic cancer in the elderly
- (2016) Oliver Higuera WORLD JOURNAL OF GASTROENTEROLOGY
- A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis
- (2016) Daniel H. Ahn et al. Therapeutic Advances in Medical Oncology
- Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy
- (2015) Tadayuki Kou et al. International Journal of Clinical Oncology
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Prognostic Factors of Survival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer
- (2015) J. Tabernero et al. ONCOLOGIST
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy
- (2014) T Hamada et al. BRITISH JOURNAL OF CANCER
- Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
- (2014) Peng Xue et al. Cancer Medicine
- Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1,082 patients
- (2013) Taira Kuroda et al. BMC GASTROENTEROLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prognostic and predictive value of serum CA19.9 in pancreatic cancer
- (2012) J. L. Humphris et al. ANNALS OF ONCOLOGY
- Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
- (2012) Todd M. Bauer et al. CANCER
- Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma
- (2011) Chigusa Morizane et al. PANCREAS
- Incidence and Survival of Pancreatic Head and Body and Tail Cancers
- (2010) Melvin K. Lau et al. PANCREAS
- Tolerance and Efficacy of Gemcitabine and Gemcitabine-Based Regimens in Elderly Patients With Advanced Pancreatic Cancer
- (2009) Raphaël Maréchal et al. PANCREAS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now